Background Transplantation of blood or bone-marrow stem cells is the treatment of choice
for selected patients with chronic myeloid leukaemia (CML). Transplantation is used with …

Chronic myelogenous leukaemia (CML) can be cured by donor marrow transplant.
Unfortunately, suitably HLA-matched related or unrelated donors are not available for the …

The introduction of imatinib mesylate has changed attitudes towards hematopoietic stem cell
transplantation (HSCT) for chronic myeloid leukemia (CML). Information on the current use …

Summary The European Group for Blood and Marrow Transplantation (EBMT) devised a
scoring system to predict survival after allogeneic haematopoietic stem cell transplantation …

In patients with chronic myelogenous leukaemia (CML) treated by allogeneic bone marrow
transplantation (BMT), detection of residual leukaemic cells carrying the characteristic …

BACKGROUND: It was investigated whether the European Group for Blood and Marrow
Transplantation risk score, previously established for chronic myeloid leukemia, could be …

The data on 1480 bone marrow transplants for chronic myeloid leukemia (CML), performed
between 1979 and 1990 were reported to the registry of the European Group for Bone …

In 117 patients with chronic myelogenous leukaemia (CML) treatment with a combination of
high-dose chemoradiotherapy plus transplantation of allogeneic bone-marrow from HLA …

Early allogeneic hematopoietic stem cell transplantation (HSCT) has been proposed as
primary treatment modality for patients with chronic myeloid leukemia (CML). This concept …

The purpose of this study was to determine the long-term results of allogeneic bone marrow
transplantation for chronic myeloid leukemia. A retrospective analysis was carried out of the …